Bowel Cancer Risk in IBD

Long-lasting inflammation repeatedly damages and repairs the bowel lining, which makes harmful cell changes more likely over time. Risk factors include a longer duration of disease, extensive colitis, ongoing active inflammation, a family history of bowel cancer, primary sclerosing cholangitis (a bile duct disease linked with IBD), and previous dysplasia. Good long-term control of inflammation lowers the risk.

The risk rises with how long the disease has been present and how much of the colon is affected. It is generally small in the first years and increases after about eight to ten years of colitis. People with disease limited to the rectum are at lower risk.

If your colonoscopy preparation or appointment falls during Ramadan, talk to your doctor beforehand about the best timing; the preparation needs a clear-fluid diet and plenty of fluid. Do not skip your surveillance for this reason.

Surveillance colonoscopy is the main tool. The endoscopist examines the whole colon carefully, often using dye spray or enhanced imaging to highlight flat abnormal areas, and takes biopsies. A pathologist examines them for dysplasia. The first surveillance colonoscopy is usually offered several years after symptoms began, and the interval afterwards depends on your individual risk factors. Your doctor decides your schedule.

Good day-to-day care of your IBD also protects against complications.

• Take your IBD medicines regularly as prescribed, even when you feel well

• Attend surveillance colonoscopies and bring a list of when you were diagnosed and which parts of the bowel are affected

• Do not smoke; smoking worsens Crohn disease and harms general health

• Report changes in symptoms early

• Keep physically active and maintain a healthy weight

Food does not cause or cure IBD-related cancer risk, but good nutrition supports recovery and health.

• Follow the dietary advice of your IBD team; needs differ during flares and remission

• Eat a varied diet with vegetables, fruit and protein as tolerated

• Limit processed meats and heavily processed foods

• Ask a dietitian before cutting out whole food groups, as this can cause deficiencies

The main preventive step is keeping inflammation under control. Your doctor chooses your medicines.

• Keep taking the IBD treatment prescribed to you; stopping it can allow inflammation to return

• Some people with ulcerative colitis take mesalamine (5-ASA) long term; discuss whether this suits you

• Tell your doctor about any new symptoms before changing doses

• If you have primary sclerosing cholangitis, your team may suggest closer surveillance

Colonoscopy surveillance finds changes early, and treatment depends on what is found.

• Surveillance colonoscopy with biopsies at intervals based on your risk

• Visible low-grade abnormal areas can often be removed through the scope

• Surgery to remove the colon may be recommended for dysplasia that cannot be safely removed, or for cancer

• Preparation for colonoscopy is more difficult during a flare; talk to your team about timing

Modern scopes with high-definition and dye-based or virtual chromoendoscopy have improved detection of subtle lesions. Many visible areas of dysplasia can now be removed through the scope rather than by surgery, followed by close surveillance. Evidence also suggests that effective control of inflammation may lower risk over the long term.

Most people with IBD do not develop bowel cancer. When surveillance finds dysplasia or an early cancer, treatment is often very effective. The best protection is controlling the inflammation, attending surveillance appointments and acting on new symptoms.

• When should my first surveillance colonoscopy be, and how often afterwards?

• Am I in a higher-risk group, for example because of the extent of my colitis or a family history?

• Is my inflammation well controlled with my current treatment?

• What happens if dysplasia is found?

• Which symptoms should make me come in before my next scheduled test?

This guide comes from the Saudi Gastroenterology Association (SGA) patient library, prepared by the Approved for publication by SGA; individual clinician review is ongoing. Last reviewed: 2026-04-24. It is for education and does not replace your doctor's advice.